RG2833

    
99%

RG2833

MedMol
S80176 一键复制产品信息
1215493-56-3
C20H25N3O2
339.43
N-(6-(2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide; UNII-17V14R89EU; RGFP 109; RG2833 (RGFP109); S7292; RG-2833;
货号 规格 价格 上海 北京 武汉 南京 购买数量
S80176-5mg 99% ¥80.00 6 - - -
S80176-10mg 99% ¥120.00 7 - - -
S80176-25mg 99% ¥160.00 6 - - -
S80176-50mg 99% ¥310.00 5 - - -
S80176-100mg 99% ¥540.00 货期:2-3天 - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品

产品介绍

RG2833 is a brain-penetrant HDAC inhibitor with IC50s of 60 nM and 50 nM for HDAC1 and HDAC3, respectively. The Ki values for HDAC1 and HDAC3 are 32 and 5 nM, respectively

产品描述: RG2833 is a brain-penetrant HDAC inhibitor with IC50s of 60 nM and 50 nM for HDAC1 and HDAC3, respectively. The Ki values for HDAC1 and HDAC3 are 32 and 5 nM, respectively
靶点: HDAC3:50 nM (IC50);HDAC1:60 nM (IC50);HDAC1:32 nM (Ki);HDAC3:5 nM (Ki);HDAC
体内研究: RG2833 (150 mg/kg) is able to correct frataxin deficiency in the brain and heart of KIKI mice 24 hours after a single injection, but not when lower doses are used. When followed in time, the frataxin mRNA increase induced by RG2833 in the KIKI mouse can be first detected at 12 hours and reach a maximum at 24 hours in both brain and heart. RG2833 (100 mg/kg, s.c.) is well tolerated in chronic dosing of mice without toxicity. RG2833 improves motor coordination of YG8R FRDA mice. RG2833 increases frataxin protein expression in the brain of YG8R FRDA mice. RGFP109 (30 mg/kg, p.o. once daily for 6 days) has no acute effects on dyskinesia after single or 6 days once-daily treatment. One week following cessation of RGFP109, dyskinesia and duration of ON-time with disabling dyskinesia are reduced by 37% and 50%, respectively
参考文献: 1. Rai M, et al. Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model. PLoS One. 2010, 5(1), e8825. 2. Sandi C, et al. Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model. Neurobiol Dis. 2011, 42(3), 496-505. 3. Johnston TH, et al. RGFP109, a histone deacetylase inhibitor attenuates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset: a proof-of-concept study. Parkinsonism Relat Disord. 2013, 19(2), 260-264.
溶解性: DMSO  :  ≥  50  mg/mL  (147.31  mM)
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.946 ml 14.731 ml 29.461 ml
5 mM 0.589 ml 2.946 ml 5.892 ml
10 mM 0.295 ml 1.473 ml 2.946 ml
50 mM 0.059 ml 0.295 ml 0.589 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×

相关产品